Zengfu Zhang, MD

Shandong Cancer Hospital and Institute
Jinan, Shandong

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 2892 - Targeting A-to-I RNA Editing and Radiation-Induced CD8+ T Cell Dysfunction in Non-Small-Cell Lung Cancer

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET

• 2907 - Targeting O-GlcNAcylation Rearrangement and Radiotherapy Sensitivity in NSCLC via the Axis of OGA/HCF1/ RAD18

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET

• 2924 - Molecular Profiling of Skin Cells Identifies Distinct Cellular Signatures in Radiation-Induced Skin Injury across Various Stages

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET

• 3122 - Cellular Senescence Index Predicts Radiotherapy Response and Outcomes in Esophagus Cancer Patients

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET

• 1152 - Radiotherapy-Induced Tumor Cell Senescence Reprograms Anti-Tumor Immunity in a p21 Dependent Manner

  Wednesday, October 2, 2024
  12:50 PM – 12:55 PM ET